August 18, 2020


Biotech & Medicine, Social Impact

About Theralase Technologies

Theralase® was one of the first companies in North America to bring CLT to patients and the first company in the world to bring personalized ACT to patient's individual tissue characteristics. With our multi-discipline experience in physics, engineering, medicine, biology, chemistry, immunology, pharmaceutical drug design, finance, business development, sales, marketing and clinical study coordination, Theralase® is staffed with the talent to drive the next level of technology for personalized healthcare in oncology and pain.